Destiny Wealth Partners, LLC Organon & Co. Transaction History

Destiny Wealth Partners, LLC

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Jan 26, 2023	SELL	$23.31 - $28.61 $5,664 - $6,952	-243 Reduced 81.82%	54 $0
Q3 2022 Oct 25, 2022	BUY	$23.4 - $34.25 $70 - $102	3 Added 1.02%	297 $7,000
Q2 2022 Jul 15, 2022	SELL	$31.66 - $38.9 $158 - $194	-5 Reduced 1.67%	294 $10,000
Q1 2022 Apr 21, 2022	BUY	$30.45 - $39.36 $60 - $78	2 Added 0.67%	299 $10,000
Q4 2021 Jan 20, 2022	BUY	$28.67 - $37.13 $86 - $111	3 Added 1.02%	297 $9,000
Q3 2021 Oct 28, 2021	BUY	$28.63 - $35.64 $8,417 - $10,478	294 New	294 $10,000

791

193M

1.71M

865K

Ticker OGN
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 254,330,000
Market Cap $3.89B
Description
Organon & Co., a health care company, develops and delivers health solutions through a portfolio of prescription therapies in the United States and internationally. Its women's health portfolio comprises contraception and fertility brands, such as Nexplanon/Implanon, a long-acting reversible contraceptive. The company's biosimilars portfolio...

Get notified when there are updates to the investment portfolio of Destiny Wealth Partners, LLC, based on Form 13F filings with the SEC.

Stay updated on Destiny Wealth Partners, LLC with notifications on news.